CLU and endometrial cancer: Six of them were upregulated in endometrial cancer patients (CLU, SERPINC1, ITIH4, C1RL, APOC3 and DSC1), while ten were downregulated (APCS, C9, APOA1, ALB, APOA4, CFHR1, ITIH2, and ACTB).